Normal growth and development in the absence of hepatic insulin-like growth factor I

AUTOR(ES)

Yakar, Shoshana

FONTE

The National Academy of Sciences

RESUMO

The somatomedin hypothesis proposed that insulin-like growth factor I (IGF-I) was a hepatically derived circulating mediator of growth hormone and is a crucial factor for postnatal growth and development. To reassess this hypothesis, we have used the Cre/loxP recombination system to delete the igf1 gene exclusively in the liver. igf1 gene deletion in the liver abrogated expression of igf1 mRNA and caused a dramatic reduction in circulating IGF-I levels. However, growth as determined by body weight, body length, and femoral length did not differ from wild-type littermates. Although our model proves that hepatic IGF-I is indeed the major contributor to circulating IGF-I levels in mice it challenges the concept that circulating IGF-I is crucial for normal postnatal growth. Rather, our model provides direct evidence for the importance of the autocrine/paracrine role of IGF-I.

Documentos Relacionados

• Bioactive Insulin-Like Growth Factor-I in Obesity
• Isolation of the human insulin-like growth factor genes: insulin-like growth factor II and insulin genes are contiguous.
• Posttranslational regulation of insulin-like growth factor binding protein-4 in normal and transformed human fibroblasts. Insulin-like growth factor dependence and biological studies.
• Insulin-like growth factors and insulin-like growth factor binding proteins in mammary gland function
• The Role of Liver-Derived Insulin-Like Growth Factor-I